News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
·
3 min read
Deals
Three Potential Takeover Targets for Amgen
March 10, 2016
·
3 min read
Job Trends
Alnylam to Build $200 Million Site in Massachusetts that Will Employ 200+ Workers
February 12, 2016
·
2 min read
Job Trends
Alnylam’s Human Resources Boss Provides Hiring Strategy, Planning to Hire 1,500 By 2020
December 9, 2015
·
3 min read
Deals
Why Amgen Should Turn Its Attention to Alnylam
November 13, 2015
·
3 min read
Policy
Alnylam Slaps Dicerna With Trade Secret Lawsuit
June 11, 2015
·
4 min read
Business
Former Sanofi Exec and Viehbacher Protoge to Join Alnylam as Senior VP
June 8, 2015
·
3 min read
Business
Booming Alnylam to Take Over Vertex’s Large Space in Cambridge
April 6, 2015
·
2 min read
Job Trends
1,075 New Jobs to be Added by 11 Life Science Firms in Massachusetts: Amgen, Alnylam, Biogen Idec, Inc. (North Carolina), GE Healthcare Bio-Sciences, Quest Diagnostics, Alkermes, Baxter Healthcare, Merrimack, Synageva BioPharma, Philips Electronics, SMC
March 19, 2015
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
December 18, 2025
·
2 min read
Press Releases
Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics
December 18, 2025
·
10 min read
Press Releases
Alnylam Announces Health Canada Approval of AMVUTTRA® (vutrisiran), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
December 17, 2025
·
10 min read
Press Releases
Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
December 12, 2025
·
4 min read
Press Releases
Alnylam Pharmaceuticals Announces Changes to Board of Directors
December 3, 2025
·
7 min read
Press Releases
Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs
November 14, 2025
·
24 min read
Press Releases
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
November 10, 2025
·
15 min read
Press Releases
Alnylam to Webcast Presentations at Upcoming November 2025 Investor Conferences
November 5, 2025
·
1 min read
Press Releases
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
October 31, 2025
·
19 min read
Press Releases
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
October 17, 2025
·
1 min read
